Kymera Therapeutics (KYMR)
(Delayed Data from NSDQ)
$49.79 USD
+0.76 (1.55%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $49.80 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.83 |
EPS Last Quarter | -0.58 |
Last EPS Surprise | 15.94% |
ABR | 1.53 |
Earnings ESP
|
-14.25% |
---|---|
Current Year | -2.87 |
Next Year | -3.43 |
EPS (TTM) | -2.42 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.97M | 13.41M | 58.33M | 58.63M |
# of Estimates | 11 | 11 | 11 | 11 |
High Estimate | 15.00M | 60.90M | 105.30M | 140.00M |
Low Estimate | 3.09M | 3.09M | 42.12M | 14.40M |
Year ago Sales | 4.73M | 47.88M | 78.59M | 58.33M |
Year over Year Growth Est. | 89.53% | -71.99% | -25.79% | 0.52% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.83 | -0.80 | -2.87 | -3.43 |
# of Estimates | 13 | 11 | 13 | 13 |
Most Recent Consensus | -0.95 | -1.00 | -3.25 | -3.77 |
High Estimate | -0.67 | -0.11 | -2.10 | -1.85 |
Low Estimate | -1.02 | -1.12 | -3.42 | -4.33 |
Year ago EPS | -0.90 | -0.25 | -2.52 | -2.87 |
Year over Year Growth Est. | 7.78% | -220.00% | -13.89% | -19.56% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 2 | 7 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 8 | 8 | 6 | 9 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.83 | -0.80 | -2.87 | -3.43 |
7 Days Ago | -0.83 | -0.80 | -2.87 | -3.43 |
30 Days Ago | -0.83 | -0.79 | -2.86 | -3.34 |
60 Days Ago | -0.74 | -0.72 | -2.86 | -3.15 |
90 Days Ago | -0.74 | -0.72 | -2.86 | -3.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.95 | -1.00 | -3.25 | -3.77 |
Zacks Consensus Estimate | -0.83 | -0.80 | -2.87 | -3.43 |
Earnings ESP | -14.25% | -25.72% | -13.24% | -9.86% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.58 | -0.69 | -0.25 | -0.90 | NA |
Estimate | -0.69 | -0.73 | -0.44 | -0.73 | NA |
Difference | 0.11 | 0.04 | 0.19 | -0.17 | 0.04 |
Surprise | 15.94% | 5.48% | 43.18% | -23.29% | 10.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more